PolarityTE, Inc. logo

PolarityTE, Inc. (PTE)

Market Closed
15 Jun, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
0. 24
-0
-0.823%
$
1.78M Market Cap
- P/E Ratio
- Div Yield
8.32M Volume
0 Eps
$ 0.24
Previous Close
Add Transaction
Day Range
0.23 0.25
Year Range
0.2 1.9
Want to track PTE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

PTE closed Thursday lower at $0.24, a decrease of -0.823% from Wednesday's close, completing a monthly increase of 0% or $0.24. Over the past 12 months, PTE stock gained 0%.
PTE is not paying dividends to its shareholders.
PolarityTE, Inc. has completed 5 stock splits, with the recent split occurring on May 17, 2022.
The company's stock is traded on one exchange.

PTE Chart

PolarityTE, Inc. (PTE) FAQ

What is the stock price today?

The current price is $0.24.

On which exchange is it traded?

PolarityTE, Inc. is listed on NASDAQ (NGS).

What is its stock symbol?

The ticker symbol is PTE.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 1.78M.

Has PolarityTE, Inc. ever had a stock split?

PolarityTE, Inc. had 5 splits and the recent split was on May 17, 2022.

PolarityTE, Inc. Profile

Biotechnology Industry
Healthcare Sector
Richard Hague CEO
NASDAQ (NGS) Exchange
731094207 CUSIP
US Country
42 Employees
- Last Dividend
17 May 2022 Last Split
- IPO Date

Overview

RegenETP, Inc. is a clinical-stage biotechnology company specializing in the development and commercialization of innovative regenerative tissue products and biomaterials. Operating primarily in the United States, the company serves the fields of medicine, biomedical engineering, and material sciences. RegenETP is structured into two main segments: Regenerative Medicine Products and Contract Services. Through its pioneering efforts, the company aims to enhance patient outcomes in various medical applications, particularly focusing on skin repair and regeneration.

Previously known as PolarityTE, Inc., the company rebranded to RegenETP, Inc. in August 2023, reflecting its commitment to advancing therapeutic solutions. Headquartered in Salt Lake City, Utah, RegenETP is dedicated to developing cutting-edge technologies that address critical medical needs.

Products and Services

  • SkinTE

    SkinTE is a regenerative tissue product specifically designed for the repair, reconstruction, replacement, and supplementation of skin. It is utilized in various medical scenarios, including the treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts. SkinTE aims to provide effective solutions for skin-related challenges faced by patients.

  • SkinTE Cryo

    SkinTE Cryo is a state-of-the-art product allowing multiple deployments from a single original harvest thanks to a cryopreservation process. This innovative approach ensures the preservation of the tissue while maintaining its viability for subsequent uses, enhancing the flexibility and effectiveness of skin regeneration treatments.

  • SkinTE Point-of-Care Device

    This point-of-care device facilitates the immediate processing and deployment of SkinTE right after the initial harvest. By enabling on-site preparation, it significantly reduces the time frame between tissue collection and application, thereby optimizing treatment outcomes for patients in urgent need of skin repairs.

  • Contract Research Services

    In addition to its regenerative medicine products, RegenETP offers contract research services to partner organizations. These services leverage the company's expertise in tissue engineering and biomaterials to support research initiatives and advance the development of new therapeutics within the industry.

  • Other Tissue Regeneration Products

    The company is actively expanding its portfolio of tissue regeneration products, focusing on innovative solutions that address various medical needs. These products are designed to enhance the regenerative capabilities of tissues beyond just skin, fostering advancements in stem cell therapy and related fields.

Contact Information

Address: 1960 South 4250 West
Phone: 800 560 3983